|
Genevest provides advisory services for institutional and sophisticated high net worth investors who have a long term investment horizon in both Technology and Life Sciences. We have more than two decades of experience in designing tailor-made investment strategies with our investors and executing careful deal selection and due diligence on a deal-by-deal basis.
Investment focus
For over 25 years, we have been advising our clients on their Venture Capital investments in Information Technology, Communications, Material Sciences, Medical Technology, Cleantech and Life Sciences. Genevest has predominantly been part of investment syndicates alongside leading Venture Capital firms. Investments have historically been between ?0.75 to ? 2.0 million with a conservative reserve policy for follow-on investments. Genevest has specialized in early to expansion stage companies with global ambitions.
Our philosophy
Great management teams build successful companies. Genevest has developed an outstanding track record of investments lead by entrepreneurs who managed to bring the companies to successful exits. At Genevest we believe that the rights of investors are as important as their obligations. We believe in the power of influence rather than control. Many of our best investments have been in companies where we held an influential minority position.
How to find us
Genevest Consulting Group
6, Cours des Bastions
1205 Geneva
Switzerland
Tel.: +41 (0)22 312 33 33
Fax: +41 (0)22 312 33 66
| 
André J. Mueller, Former Senior Vice President, former Member of the Business Executive Board and Vice-President the Board of Directors of Actelion Ltd. and part of the founding team.